Page last updated: 2024-08-20

yohimbine and Depressive Disorder, Major

yohimbine has been researched along with Depressive Disorder, Major in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (16.67)18.2507
2000's1 (16.67)29.6817
2010's1 (16.67)24.3611
2020's3 (50.00)2.80

Authors

AuthorsStudies
Deuter, CE; Kuehl, LK; Nowacki, J; Otte, C; Ueberrueck, L; Wingenfeld, K1
Deuter, CE; Hellmann-Regen, J; Kaczmarczyk, M; Kuehl, LK; Otte, C; Wingenfeld, K1
Breden, IH; Deuter, CE; Kuehl, LK; Otte, C; Schulz, A; Vögele, C; Wingenfeld, K1
Kuehl, LK; Kuffel, A; Löwe, B; Otte, C; Schreiner, J; Spitzer, C; Terfehr, K; Uhlmann, C; Wingenfeld, K1
Berman, RM; Cappiello, A; Charney, DS; Fasula, D; Gueorguieva, R; Kugaya, A; Liu, N; Oren, DA; Sanacora, G1
Griffith, JM; Gurguis, GN; Rush, AJ; Vo, SP1

Trials

2 trial(s) available for yohimbine and Depressive Disorder, Major

ArticleYear
Effects of noradrenergic stimulation on memory in patients with major depressive disorder.
    Stress (Amsterdam, Netherlands), 2013, Volume: 16, Issue:2

    Topics: Adrenergic alpha-2 Receptor Antagonists; Adult; Blood Pressure; Cross-Over Studies; Depressive Disorder, Major; Double-Blind Method; Female; Humans; Male; Memory; Salivary alpha-Amylases; Yohimbine

2013
Addition of the alpha2-antagonist yohimbine to fluoxetine: effects on rate of antidepressant response.
    Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2004, Volume: 29, Issue:6

    Topics: Adolescent; Adrenergic alpha-Antagonists; Adult; Aged; Antidepressive Agents; Depressive Disorder, Major; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Female; Fluoxetine; Humans; Male; Middle Aged; Personality Inventory; Psychiatric Status Rating Scales; Treatment Outcome; Yohimbine

2004

Other Studies

4 other study(ies) available for yohimbine and Depressive Disorder, Major

ArticleYear
Attentional bias in individuals with depression and adverse childhood experiences: influence of the noradrenergic system?
    Psychopharmacology, 2021, Volume: 238, Issue:12

    Topics: Attentional Bias; Depression; Depressive Disorder, Major; Humans; Norepinephrine; Yohimbine

2021
Enhanced noradrenergic activity by yohimbine and differential fear conditioning in patients with major depression with and without adverse childhood experiences.
    Progress in neuro-psychopharmacology & biological psychiatry, 2020, 01-10, Volume: 96

    Topics: Adrenergic alpha-2 Receptor Antagonists; Adult; Adverse Childhood Experiences; alpha-Amylases; Child; Conditioning, Psychological; Cross-Sectional Studies; Depressive Disorder, Major; Fear; Female; Humans; Male; Middle Aged; Norepinephrine; Photic Stimulation; Yohimbine

2020
Noradrenergic activation induced by yohimbine decreases interoceptive accuracy in healthy individuals with childhood adversity.
    Development and psychopathology, 2022, Volume: 34, Issue:3

    Topics: Adverse Childhood Experiences; Depressive Disorder, Major; Humans; Interoception; Receptors, Adrenergic; Yohimbine

2022
Platelet alpha2A-adrenoceptor function in major depression: Gi coupling, effects of imipramine and relationship to treatment outcome.
    Psychiatry research, 1999, Dec-20, Volume: 89, Issue:2

    Topics: Adrenergic Uptake Inhibitors; Adult; Antidepressive Agents, Tricyclic; Biomarkers; Blood Platelets; Case-Control Studies; Depressive Disorder, Major; GTP-Binding Protein alpha Subunits, Gi-Go; Humans; Imipramine; Male; Middle Aged; Norepinephrine; Protein Binding; Protein Kinases; Psychiatric Status Rating Scales; Receptors, Adrenergic, alpha-2; Treatment Outcome; Yohimbine

1999